Pulmonary infection in mild variant cystic fibrosis: Implications for care

Journal of Cystic Fibrosis

Volumn 5, Issue 2, 2006, Pages 101-104

  Lording, A ^a   McGaw, J ^a   Dalton, A ^a   Beal, G ^a   Everard, M ^a   Taylor, C J ^a  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Cystic fibrosis; Infection; Mild genotype

Indexed keywords

ANTIBIOTIC AGENT; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; FREQUENCY ANALYSIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LUNG FUNCTION; LUNG INFECTION; MALE; MUTATIONAL ANALYSIS; PATIENT CARE; PHENOTYPIC VARIATION; PROGNOSIS; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SCORING SYSTEM; STAPHYLOCOCCUS AUREUS; THORAX RADIOGRAPHY;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUTATION; PHENOTYPE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPUTUM; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 33645998389     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2005.11.005     Document Type: Article

References (22)

1. Koch C., Cuppens H., Rainisio M., Madessani U., Harms H., Hodson M., et al. Investigators of the ERCF. European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol 31 1 (Jan 2001) 1-12
2. Chmiel J.F., Drumm M.L., Konstan M.W., Ferkol T.W., and Kercsmar C.M. Pitfalls in the use of genotype analysis as the sole diagnostic criterion for cystic fibrosis. Pediatrics 103 (1999) 823-826
3. Curnow L., Savarirayan R., and Massie J. Genetic counselling after carrier detection by newborn screening when one parent carries DeltaF508 and the other R117H. Arch Dis Child 88 10 (Oct 2003) 886-888
4. McKone E.F., Emerson S.S., Edwards K.L., and Aitken M.L. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet 361 9370 (May 17 2003) 1671-1676
5. Taylor C.J., Dalton A., and Pirzada O. Cystic fibrosis mutations and disease phenotype. Arch Dis Child 83 2 (Aug 2000) 185
6. Antibiotic treatment for cystic fibrosis: 8 Microbiological Appendices. Report of the UK Cystic Fibrosis Antibiotic Group, September 2002.
7. Shwachman H., and Kulczycki L.L. Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. Am J Dis Child 96 (1958) 6-15
8. Chrispin A.R., and Norman A.P. The systematic evaluation of a chest radiograph in cystic fibrosis. Pediatr Radiol 2 (1974) 101-106
9. Polgar G., and Promadlist U. Pulmonary function testing in children (1971), W.B. Saunders and Co, Philadelphia
10. Frederiksen B., Koch C., and Hoiby N. Antibiotic treatment at time of initial colonisation with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration in pulmonary function in patients with cystic fibrosis. Pediatr Pulmonol 23 (1977) 330-335
11. Mickle J.E., and Cutting G.R. Genotype-phenotype relationships in cystic fibrosis. Med Clin North Am 84 3 (May 2000) 597-607
12. Zielenski J. Genotype and phenotype in cystic fibrosis. Respiration 67 2 (2000) 117-133
13. Dreyfus D.H., Bethel R., and Gelfand E.W. Cystic fibrosis 3849 + 10 kb C > T mutation associated with severe pulmonary disease and male fertility. Am J Respir Crit Care Med 153 2 (Feb 1996) 858-860
14. Armstrong D.S., Grimwood K., Carlin J.B., Carzino R., Olinsky A., and Phelan P.D. Bronchoalveolar lavage and oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr Pulmonol 21 (1996) 267-275
15. Antibiotic treatment for cystic fibrosis. Report of the UK cystic fibrosis trust antibiotic group. Cystic Fibrosis Trust (2002) 16-24
16. Weaver L.T., Green M.R., Nicholson K., Mills J., Heeley M.E., Kuzemko J.A., et al. Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period. Arch Dis Child 70 2 (Feb 1994) 84-89
17. Szaff M., and Hoiby N. Antibiotic treatment of Staphylococcal aureus infection in cystic fibrosis. ACTA Paediatr Scand 71 (1982) 821-826
18. Lai H.J., Cheng Y., Cho H., Kosorok M.R., and Farrell P.M. Association between initial disease presentation, lung disease outcomes, and survival in patients with cystic fibrosis. Am J Epidemiol 159 6 (Mar 15 2004) 537-546
19. Valerius N.H., Koch C., and Hoiby N. Prevention of coronic Pseudomonas aeruginosa infection in cystic fibrosis by early treatment. Lancet 338 (1991) 725-726
20. Marchetti F., Giglio L., Candusso M., Faraguna D., and Assael B.M. Early antibiotic treatment of Pseudomonas aeruginosa colonisation in cystic fibrosis: a critical review of the literature. Eur J Clin Pharmacol (2004 (Mar. 5))
21. Zemel B.S., Jawad A.F., FitzSimmons S., and Stallings V.A. Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry. J Pediatr 137 3 (Sep 2000) 374-380
22. Demirkazik F.B., Ariyurek O.M., Ozcelik U., Gocmen A., Hassanabad H.K., and Kiper N. High resolution CT in children with cystic fibrosis: correlation with pulmonary functions and radiographic scores. Eur J Radiol 37 1 (2001) 54-59